Literature DB >> 18328840

Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention.

Mark D Osten1, Joan Ivanov, Jonas Eichhofer, Peter H Seidelin, John R Ross, Alan Barolet, Eric M Horlick, Douglas Ing, Leonard Schwartz, Karen Mackie, Vladimír Dzavík.   

Abstract

Patients with chronic renal insufficiency (RI) have higher in-hospital mortality and major adverse cardiac event (MACE) rates after percutaneous coronary intervention (PCI). The mechanisms of this adverse course are not well understood. It was hypothesized that this worse outcome may be caused by inadequate PCI results secondary to more complex coronary anatomy in patients with RI. Baseline, procedural, and outcome variables of all PCI cases at the University Health Network are entered prospectively in the PCI Registry. All PCI cases between April 1, 2000, and October 31, 2005, excluding patients in shock, who had preprocedural creatinine clearance (CrCl) measured were included in this study (n = 10,821 of 11,023 patients). Moderate RI (CrCl <60 ml/min) was evaluated as an independent predictor of procedural outcomes, death, and MACE (defined as death, myocardial infarction, abrupt closure, or coronary artery bypass grafting). Moderate RI (CrCl <60 ml/min) independently predicted the procedural outcomes of worse residual stenosis >20% (p = 0.03), number of undeliverable stents (p = 0.003), and smallest stent diameter (p <0.001). Worst residual stenosis >20% and any undeliverable stent were significantly associated with in-hospital MACEs (odds ratio [OR] 3.97, 95% confidence interval [CI] 3.0 to 5.3, p <0.001 and OR 1.89, 95% CI 1.2 to 2.9, p = 0.002) and mortality (OR 3.82, 95% CI 2.2 to 6.7, p <0.001 and OR 3.0, 95% CI 1.6 to 5.9, p = 0.002). These risks were independent of all other measured variables. In conclusion, moderate to severe RI was a strong predictor of worse procedural results during PCI, which, in turn, were independent predictors of in-hospital MACE and mortality and independent contributors to the higher risk of in-hospital adverse events observed after PCI in patients with RI.

Entities:  

Mesh:

Year:  2008        PMID: 18328840     DOI: 10.1016/j.amjcard.2007.11.009

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.

Authors:  Ayman A El-Menyar; Jassim Al Suwaidi; David R Holmes
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

2.  Late outcomes following percutaneous coronary interventions: results from a large, observational registry.

Authors:  Clare E Appleby; Karen Mackie; Vladimír Dzavík; Joan Ivanov
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

3.  Mild renal insufficiency and attributable risk of adverse In-hospital outcomes in patients with Acute Coronary Syndrome from the improving care for Cardiovascular Disease in China (CCC) project.

Authors:  Fengbo Xu; Guoqin Wang; Nan Ye; Weijing Bian; Lijiao Yang; Changsheng Ma; Dong Zhao; Jing Liu; Yongchen Hao; Jun Liu; Na Yang; Hong Cheng
Journal:  BMC Nephrol       Date:  2022-01-13       Impact factor: 2.388

4.  The impact of stage of chronic kidney disease on the outcomes of diabetics with acute myocardial infarction treated with percutaneous coronary intervention.

Authors:  Teodora Vichova; Jiri Knot; Jaroslav Ulman; Marek Maly; Zuzana Motovska
Journal:  Int Urol Nephrol       Date:  2016-03-19       Impact factor: 2.370

5.  Impact of renal function on argatroban therapy during percutaneous coronary intervention.

Authors:  Marcie J Hursting; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2010-01       Impact factor: 2.300

6.  Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention.

Authors:  Tanush Gupta; Neha Paul; Dhaval Kolte; Prakash Harikrishnan; Sahil Khera; Wilbert S Aronow; Marjan Mujib; Chandrasekar Palaniswamy; Sachin Sule; Diwakar Jain; Ali Ahmed; Howard A Cooper; William H Frishman; Deepak L Bhatt; Gregg C Fonarow; Julio A Panza
Journal:  J Am Heart Assoc       Date:  2015-06-16       Impact factor: 5.501

7.  Chronic kidney disease is associated with adverse outcomes among elderly patients taking clopidogrel after hospitalization for acute coronary syndrome.

Authors:  Michael J Fischer; P Michael Ho; Kelly McDermott; Elliott Lowy; Chirag R Parikh
Journal:  BMC Nephrol       Date:  2013-05-20       Impact factor: 2.388

8.  Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction.

Authors:  Xiaojia Zhang; Liangping Hu; Wen Zheng
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.